Search Results

You are looking at 1 - 10 of 33 items for :

  • "bone sarcoma" x
Clear All
Full access

Rashmi Chugh

and refractory setting of both diseases. Chondrosarcoma remains a disease without any effective systemic therapy. This article provides an overview of currently available experimental treatments and clinical trials in bone sarcomas, and the

Full access

Judd E. Cummings, J. Andrew Ellzey and Robert K. Heck

the course of chemotherapy: a study in patients with bone sarcoma . Skeletal Radiol 1994 ; 23 : 181 – 185 . 50. Li KC Hopkins KL Moore SG . Magnetization transfer contrast MRI of musculoskeletal neoplasms . Skeletal Radiol 1995 ; 24

Full access

Carol D. Morris

Despite decades of success in the management of bone sarcomas, the pelvis remains an elusive anatomic site for all members of the bone sarcoma disease management team. Surgeons continue to struggle to obtain negative margins and reconstruct a

Full access

Suzanne George

discussed updates in the treatment of STS. “This space has been much more active with regard to drug development and new drug indications than the bone sarcomas space,” she noted. “But hopefully that will change soon.” Overview of Sarcomas Sarcomas are a

Full access

Scott M. Schuetze

for patients aged under 40 years with bone sarcoma in Britain, 1980–1994 . Br J Cancer 2006 ; 94 : 22 – 29 . 4. Bacci G Mercuri M Longhi A . Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: a comparison of

Full access

Andrew Wagner

versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group . J Clin Oncol 1995 , 13

Full access

Somaiah Neeta MD Yasko Alan W. MD 6 2010 8 8 6 6 688 688 712 712 0080688 10.6004/jnccn.2010.0051 Experimental Therapies and Clinical Trials in Bone Sarcoma Chugh Rashmi MD 6 2010 8 8 6 6 715 715 725 725 0080715 10.6004/jnccn

Full access

420 420 420 420 0050420 10.6004/jnccn.2007.0037 Imaging of Bone Sarcomas Cummings Judd E. MD Ellzey J. Andrew MD Heck Robert K. MD 04 2007 5 5 4 4 438 438 447 447 0050438 10.6004/jnccn.2007.0038 Chemotherapy in the Management of

Full access

J. Sybil Biermann

optimally it should be performed at a center that will do definitive management. “The problem with bone sarcomas is they are mesenchymally derived tissues,” explained Dr. Biermann. “So unlike carcinomas, they seed the tissues on the way out, and everywhere

Full access

Margaret von Mehren, R. Lor Randall, Robert S. Benjamin, Sarah Boles, Marilyn M. Bui, Ernest U. Conrad III, Kristen N. Ganjoo, Suzanne George, Ricardo J. Gonzalez, Martin J. Heslin, John M. Kane III, Henry Koon, Joel Mayerson, Martin McCarter, Sean V. McGarry, Christian Meyer, Richard J. O'Donnell, Alberto S. Pappo, I. Benjamin Paz, Ivy A. Petersen, John D. Pfeifer, Richard F. Riedel, Scott Schuetze, Karen D. Schupak, Herbert S. Schwartz, William D. Tap, Jeffrey D. Wayne, Mary Anne Bergman and Jillian Scavone

sheath, blood vessels, and other connective tissues); and Sarcomas of bone. Sarcomas collectively account for approximately 1% of all adult malignancies and 15% of pediatric malignancies. In 2016, an estimated 12,310 people will be diagnosed with